Picture of Evaxion A/S logo

EVAX — Evaxion A/S News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Evaxion Expects Existing Cash, Cash Equivalents To Be Sufficient Into Q1 2025

May 28 (Reuters) - Evaxion Biotech A/S  EVAX.O :
    * ANNOUNCES BUSINESS UPDATE AND FIRST QUARTER 2024 FINANCIAL
RESULTS
    * EXPECTS EXISTING CASH AND CASH EQUIVALENTS WILL BE
SUFFICIENT TO
FUND ITS OPERATING EXPENSES AND CAPEX REQUIREMENTS INTO Q1 2025

Source text for Eikon:  ID:nGNX34Mzs2 
Further company coverage:  EVAX.O 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Evaxion A/S

See all news